- Madeed raises USD 400K pre-seed led by Vision Ventures to build a preventative health platform focused on lifespan extension.
- Platform leverages lab testing to detect early warning signs of hundreds of diseases, prioritizing disease prevention and long-term health optimization.
- The funding will aid product launch and expand clinical partnerships, aiming to onboard initial members with a primary focus on the Saudi market.
Madeed
Saudi-based Madeed raised USD 400 thousand in a pre-seed round. The round was led by Vision Ventures (VV), with participation from investors including Mashhoor Aldubayan, Mazen Aldarrab, and Abdulla Nadeem Elyas.
Founded by Adam Bataineh, Madeed is a preventative health platform. It is building a longevity platform with a focus on true disease prevention and health optimization. It uses advanced laboratory testing to identify early risk signals across hundreds of diseases before symptoms appear.
“We built Madeed to flip that model using data, AI, and clinical oversight to help people optimize their health, understand risk early and act decisively, long before disease takes hold,” said Dr. Adam Bataineh, Founder and CEO of Madeed.
Preventive Health
The platform gives members access to comprehensive blood and biomarker testing, comprehensive health reports, and clinician-reviewed notes. This translates complex data into clear insights across key domains such as metabolic health, hormone balance, cardiovascular risk, and inflammation.
Beyond diagnostics, it aims to deliver actionable, personalized protocols covering lifestyle, nutrition, and supplementation. These protocols intend to help individuals proactively optimize their long-term health.
The platform’s main selling point is its custom-designed daily supplement pill. The pill is formulated specifically for each member based on their blood test results.
Looking forward, with the capital, it aims finalize its product development. It also aims to expand clinical and lab partnerships across the region. In addition, it seeks to onboard the first cohort of members, with an initial focus on Saudi Arabia.
If you see something out of place or would like to contribute to this story, check out our Ethics and Policy section.









